Cargando…

Comparison of the protective antigen variabilities of prevalent Newcastle disease viruses in response to homologous/heterologous genotype vaccines

The genotype VII Newcastle disease virus (NDV) vaccine has begun to replace the traditional genotype II NDV vaccine and is widely used in the commercial poultry of China. However, the effect of homologous and heterogeneous anti-NDV serum on the evolution of prevalent NDV is unknown. To understand th...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yonghua, Rehman, Zaib Ur, Li, Mengjiao, Manzoor, Zahid, Liu, Wei, Qiu, Xusheng, Sun, Yingjie, Liao, Ying, Tan, Lei, Song, Cuiping, Liu, Weiwei, Yu, Shengqing, Ding, Chan, Meng, Chunchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267594/
https://www.ncbi.nlm.nih.gov/pubmed/34237546
http://dx.doi.org/10.1016/j.psj.2021.101267
_version_ 1783720174943207424
author Li, Yonghua
Rehman, Zaib Ur
Li, Mengjiao
Manzoor, Zahid
Liu, Wei
Qiu, Xusheng
Sun, Yingjie
Liao, Ying
Tan, Lei
Song, Cuiping
Liu, Weiwei
Yu, Shengqing
Ding, Chan
Meng, Chunchun
author_facet Li, Yonghua
Rehman, Zaib Ur
Li, Mengjiao
Manzoor, Zahid
Liu, Wei
Qiu, Xusheng
Sun, Yingjie
Liao, Ying
Tan, Lei
Song, Cuiping
Liu, Weiwei
Yu, Shengqing
Ding, Chan
Meng, Chunchun
author_sort Li, Yonghua
collection PubMed
description The genotype VII Newcastle disease virus (NDV) vaccine has begun to replace the traditional genotype II NDV vaccine and is widely used in the commercial poultry of China. However, the effect of homologous and heterogeneous anti-NDV serum on the evolution of prevalent NDV is unknown. To understand the effect of genotype II and VII anti-NDV serum on the evolution of genotype VII NDV strains, ZJ1 (waterfowl origin) and CH/SD/2008/128 (ND128; chicken origin) were used for serial passage of 30 generations in DF-1 cells without anti-NDV serum or with genotype II and VII anti-NDV serum independently. The F and HN genes of the 2 viruses were amplified for the 10th, 20th, and 30th generations of each serial passage group and compared with their respective original viruses. We found that there was only one mutation at position 248 in the F gene of ZJ1 due to the serum pressure of genotype VII anti-NDV. Similarly, mutations at residue 527 of the F gene, and position 9 and 319 of the HN gene of ND128 were noted in both anti-NDV serum groups. The results show that the nonsynonymous (NS)-to-synonymous (S) ratio of the F gene of ZJ1 virus was 1.6, and for the HN gene, it was 2.5 in the anti-II serum group. In the anti-VII serum group, the NS/S ratio for the F gene was 2.1, and for the HN gene, it was 2.5. The NS/S ratio of the F gene of the ND128 virus was 0.8, and for the HN gene, it was 3 in the anti-II serum group. Furthermore, the NS/S ratio of the F gene was 0.8, and the HN gene was 2.3 in the anti-VII group. Taken together, our findings highlight that there was no significant difference in the variation of protective antigens in genotype VII NDV under the selection pressure of homologous and heterogeneous genotype NDV inactivated vaccines.
format Online
Article
Text
id pubmed-8267594
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-82675942021-07-16 Comparison of the protective antigen variabilities of prevalent Newcastle disease viruses in response to homologous/heterologous genotype vaccines Li, Yonghua Rehman, Zaib Ur Li, Mengjiao Manzoor, Zahid Liu, Wei Qiu, Xusheng Sun, Yingjie Liao, Ying Tan, Lei Song, Cuiping Liu, Weiwei Yu, Shengqing Ding, Chan Meng, Chunchun Poult Sci IMMUNOLOGY, HEALTH AND DISEASE The genotype VII Newcastle disease virus (NDV) vaccine has begun to replace the traditional genotype II NDV vaccine and is widely used in the commercial poultry of China. However, the effect of homologous and heterogeneous anti-NDV serum on the evolution of prevalent NDV is unknown. To understand the effect of genotype II and VII anti-NDV serum on the evolution of genotype VII NDV strains, ZJ1 (waterfowl origin) and CH/SD/2008/128 (ND128; chicken origin) were used for serial passage of 30 generations in DF-1 cells without anti-NDV serum or with genotype II and VII anti-NDV serum independently. The F and HN genes of the 2 viruses were amplified for the 10th, 20th, and 30th generations of each serial passage group and compared with their respective original viruses. We found that there was only one mutation at position 248 in the F gene of ZJ1 due to the serum pressure of genotype VII anti-NDV. Similarly, mutations at residue 527 of the F gene, and position 9 and 319 of the HN gene of ND128 were noted in both anti-NDV serum groups. The results show that the nonsynonymous (NS)-to-synonymous (S) ratio of the F gene of ZJ1 virus was 1.6, and for the HN gene, it was 2.5 in the anti-II serum group. In the anti-VII serum group, the NS/S ratio for the F gene was 2.1, and for the HN gene, it was 2.5. The NS/S ratio of the F gene of the ND128 virus was 0.8, and for the HN gene, it was 3 in the anti-II serum group. Furthermore, the NS/S ratio of the F gene was 0.8, and the HN gene was 2.3 in the anti-VII group. Taken together, our findings highlight that there was no significant difference in the variation of protective antigens in genotype VII NDV under the selection pressure of homologous and heterogeneous genotype NDV inactivated vaccines. Elsevier 2021-05-19 /pmc/articles/PMC8267594/ /pubmed/34237546 http://dx.doi.org/10.1016/j.psj.2021.101267 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle IMMUNOLOGY, HEALTH AND DISEASE
Li, Yonghua
Rehman, Zaib Ur
Li, Mengjiao
Manzoor, Zahid
Liu, Wei
Qiu, Xusheng
Sun, Yingjie
Liao, Ying
Tan, Lei
Song, Cuiping
Liu, Weiwei
Yu, Shengqing
Ding, Chan
Meng, Chunchun
Comparison of the protective antigen variabilities of prevalent Newcastle disease viruses in response to homologous/heterologous genotype vaccines
title Comparison of the protective antigen variabilities of prevalent Newcastle disease viruses in response to homologous/heterologous genotype vaccines
title_full Comparison of the protective antigen variabilities of prevalent Newcastle disease viruses in response to homologous/heterologous genotype vaccines
title_fullStr Comparison of the protective antigen variabilities of prevalent Newcastle disease viruses in response to homologous/heterologous genotype vaccines
title_full_unstemmed Comparison of the protective antigen variabilities of prevalent Newcastle disease viruses in response to homologous/heterologous genotype vaccines
title_short Comparison of the protective antigen variabilities of prevalent Newcastle disease viruses in response to homologous/heterologous genotype vaccines
title_sort comparison of the protective antigen variabilities of prevalent newcastle disease viruses in response to homologous/heterologous genotype vaccines
topic IMMUNOLOGY, HEALTH AND DISEASE
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267594/
https://www.ncbi.nlm.nih.gov/pubmed/34237546
http://dx.doi.org/10.1016/j.psj.2021.101267
work_keys_str_mv AT liyonghua comparisonoftheprotectiveantigenvariabilitiesofprevalentnewcastlediseasevirusesinresponsetohomologousheterologousgenotypevaccines
AT rehmanzaibur comparisonoftheprotectiveantigenvariabilitiesofprevalentnewcastlediseasevirusesinresponsetohomologousheterologousgenotypevaccines
AT limengjiao comparisonoftheprotectiveantigenvariabilitiesofprevalentnewcastlediseasevirusesinresponsetohomologousheterologousgenotypevaccines
AT manzoorzahid comparisonoftheprotectiveantigenvariabilitiesofprevalentnewcastlediseasevirusesinresponsetohomologousheterologousgenotypevaccines
AT liuwei comparisonoftheprotectiveantigenvariabilitiesofprevalentnewcastlediseasevirusesinresponsetohomologousheterologousgenotypevaccines
AT qiuxusheng comparisonoftheprotectiveantigenvariabilitiesofprevalentnewcastlediseasevirusesinresponsetohomologousheterologousgenotypevaccines
AT sunyingjie comparisonoftheprotectiveantigenvariabilitiesofprevalentnewcastlediseasevirusesinresponsetohomologousheterologousgenotypevaccines
AT liaoying comparisonoftheprotectiveantigenvariabilitiesofprevalentnewcastlediseasevirusesinresponsetohomologousheterologousgenotypevaccines
AT tanlei comparisonoftheprotectiveantigenvariabilitiesofprevalentnewcastlediseasevirusesinresponsetohomologousheterologousgenotypevaccines
AT songcuiping comparisonoftheprotectiveantigenvariabilitiesofprevalentnewcastlediseasevirusesinresponsetohomologousheterologousgenotypevaccines
AT liuweiwei comparisonoftheprotectiveantigenvariabilitiesofprevalentnewcastlediseasevirusesinresponsetohomologousheterologousgenotypevaccines
AT yushengqing comparisonoftheprotectiveantigenvariabilitiesofprevalentnewcastlediseasevirusesinresponsetohomologousheterologousgenotypevaccines
AT dingchan comparisonoftheprotectiveantigenvariabilitiesofprevalentnewcastlediseasevirusesinresponsetohomologousheterologousgenotypevaccines
AT mengchunchun comparisonoftheprotectiveantigenvariabilitiesofprevalentnewcastlediseasevirusesinresponsetohomologousheterologousgenotypevaccines